Stocks and Investing Stocks and Investing
Mon, July 15, 2024

Matt O"Brien Maintained (TMDX) at Buy with Increased Target to $170 on, Jul 15th, 2024


Published on 2024-10-28 12:27:15 - WOPRAI, Matt O'Brien
  Print publication without navigation


Matt O"Brien of Piper Sandler, Maintained "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $120 to $170 on, Jul 15th, 2024.

Matt has made no other calls on TMDX in the last 4 months.

There are 5 other peers that have a rating on TMDX. Out of the 5 peers that are also analyzing TMDX, 0 agree with Matt"s Rating of Hold.

These are the ratings of the 5 analyists that currently disagree with Matt;

Joshua Jennings of "TD Cowen" Maintained at Strong Buy with Increased Target to $175 on, Friday, June 7th, 2024
George Sellers of "Stephens & Co." Initiated at Buy and Held Target at $151 on, Tuesday, June 4th, 2024
Jason Mills of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $117 on, Wednesday, May 1st, 2024
Suraj Kalia of "Oppenheimer" Maintained at Buy with Increased Target to $125 on, Wednesday, May 1st, 2024
Allen Gong of "JP Morgan" Maintained at Buy with Increased Target to $127 on, Wednesday, May 1st, 2024


Contributing Sources